Literature DB >> 19637346

Validity assessment of the Breast Cancer Risk Reduction Health Belief scale.

Mfon Cyrus-David1, Jason King, Therese Bevers, Emily Robinson.   

Abstract

BACKGROUND: : Women at increased risk of breast cancer (BC) are not widely accepting of chemopreventive interventions, and ethnic minorities are underrepresented in related trials. Furthermore, there is no validated instrument to assess the health-seeking behavior of these women with respect to these interventions.
METHODS: : By using constructs from the Health Belief Model, the authors developed and refined, based on pilot data, the Breast Cancer Risk Reduction Health Belief (BCRRHB) scale using a population of 265 women at increased risk of BC who were largely medically underserved, of low socioeconomic status (SES), and ethnic minorities. Construct validity was assessed using principal components analysis with oblique rotation to extract factors, and generate and interpret summary scales. Internal consistency was determined using Cronbach alpha coefficients.
RESULTS: : Test-retest reliability for the pilot and final data was calculated to be r = 0.85. Principal components analysis yielded 16 components that explained 64% of the total variance, with communalities ranging from 0.50-0.75. Cronbach alpha coefficients for the extracted factors ranged from 0.45-0.77.
CONCLUSIONS: : Evidence suggests that the BCRRHB yields reliable and valid data that allows for the identification of barriers and enhancing factors associated with use of breast cancer chemoprevention in the study population. These findings allow for tailoring treatment plans and intervention strategies to the individual. Future research is needed to validate the scale for use in other female populations. Cancer 2009. (c) 2009 American Cancer Society.

Entities:  

Mesh:

Year:  2009        PMID: 19637346      PMCID: PMC2768118          DOI: 10.1002/cncr.24541

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  42 in total

1.  Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Authors:  Victor G Vogel; Joseph P Costantino; D Lawrence Wickerham; Walter M Cronin; Reena S Cecchini; James N Atkins; Therese B Bevers; Louis Fehrenbacher; Eduardo R Pajon; James L Wade; André Robidoux; Richard G Margolese; Joan James; Scott M Lippman; Carolyn D Runowicz; Patricia A Ganz; Steven E Reis; Worta McCaskill-Stevens; Leslie G Ford; V Craig Jordan; Norman Wolmark
Journal:  JAMA       Date:  2006-06-05       Impact factor: 56.272

2.  Timely follow-up among multicultural women with abnormal mammograms.

Authors:  Pamela Arnsberger; Patrick Fox; Priscilla Ryder; Brenda Nussey; Xiulan Zhang; Regina Otero-Sabogal
Journal:  Am J Health Behav       Date:  2006 Jan-Feb

3.  Reliability and validity of breast cancer screening belief scales in African American women.

Authors:  V L Champion; C R Scott
Journal:  Nurs Res       Date:  1997 Nov-Dec       Impact factor: 2.381

4.  Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.

Authors:  B Rockhill; D Spiegelman; C Byrne; D J Hunter; G A Colditz
Journal:  J Natl Cancer Inst       Date:  2001-03-07       Impact factor: 13.506

5.  Fragmentation of care for frequently hospitalized urban residents.

Authors:  Deborah Schrag; Feng Xu; Morgan Hanger; Elena Elkin; Nina A Bickell; Peter B Bach
Journal:  Med Care       Date:  2006-06       Impact factor: 2.983

6.  First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial.

Authors:  J Cuzick; J Forbes; R Edwards; M Baum; S Cawthorn; A Coates; A Hamed; A Howell; T Powles
Journal:  Lancet       Date:  2002-09-14       Impact factor: 79.321

7.  The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention Trial.

Authors:  A Y Kinney; C Richards; S W Vernon; V G Vogel
Journal:  Prev Med       Date:  1998 Sep-Oct       Impact factor: 4.018

Review 8.  Do stress-related psychosocial factors contribute to cancer incidence and survival?

Authors:  Yoichi Chida; Mark Hamer; Jane Wardle; Andrew Steptoe
Journal:  Nat Clin Pract Oncol       Date:  2008-05-20

9.  Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer.

Authors:  Russell McBride; Dawn Hershman; Wei-Yann Tsai; Judith S Jacobson; Victor Grann; Alfred I Neugut
Journal:  Cancer       Date:  2007-09-15       Impact factor: 6.860

10.  Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.

Authors:  Lisa K Dunnwald; Mary Anne Rossing; Christopher I Li
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more
  1 in total

1.  Knowledge and accuracy of perceived personal risk in underserved women who are at increased risk of breast cancer.

Authors:  Mfon S Cyrus-David
Journal:  J Cancer Educ       Date:  2010-12       Impact factor: 2.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.